209 related articles for article (PubMed ID: 9804616)
1. Studies on the mechanism of resistance to rapamycin in human cancer cells.
Hosoi H; Dilling MB; Liu LN; Danks MK; Shikata T; Sekulic A; Abraham RT; Lawrence JC; Houghton PJ
Mol Pharmacol; 1998 Nov; 54(5):815-24. PubMed ID: 9804616
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin causes poorly reversible inhibition of mTOR and induces p53-independent apoptosis in human rhabdomyosarcoma cells.
Hosoi H; Dilling MB; Shikata T; Liu LN; Shu L; Ashmun RA; Germain GS; Abraham RT; Houghton PJ
Cancer Res; 1999 Feb; 59(4):886-94. PubMed ID: 10029080
[TBL] [Abstract][Full Text] [Related]
3. 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin.
Dilling MB; Germain GS; Dudkin L; Jayaraman AL; Zhang X; Harwood FC; Houghton PJ
J Biol Chem; 2002 Apr; 277(16):13907-17. PubMed ID: 11847216
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
[TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
[TBL] [Abstract][Full Text] [Related]
6. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells.
Beevers CS; Li F; Liu L; Huang S
Int J Cancer; 2006 Aug; 119(4):757-64. PubMed ID: 16550606
[TBL] [Abstract][Full Text] [Related]
8. Determinants of rapamycin sensitivity in breast cancer cells.
Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
10. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition.
Dudkin L; Dilling MB; Cheshire PJ; Harwood FC; Hollingshead M; Arbuck SG; Travis R; Sausville EA; Houghton PJ
Clin Cancer Res; 2001 Jun; 7(6):1758-64. PubMed ID: 11410517
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits F-actin reorganization and phosphorylation of focal adhesion proteins.
Liu L; Chen L; Chung J; Huang S
Oncogene; 2008 Aug; 27(37):4998-5010. PubMed ID: 18504440
[TBL] [Abstract][Full Text] [Related]
12. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1.
Burnett PE; Barrow RK; Cohen NA; Snyder SH; Sabatini DM
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1432-7. PubMed ID: 9465032
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
El-Chaâr D; Gagnon A; Sorisky A
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
[TBL] [Abstract][Full Text] [Related]
14. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.
Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N
BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
[TBL] [Abstract][Full Text] [Related]
16. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.
Hidalgo M; Rowinsky EK
Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655
[TBL] [Abstract][Full Text] [Related]
17. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin.
Shu L; Zhang X; Houghton PJ
J Biol Chem; 2002 May; 277(19):16726-32. PubMed ID: 11875068
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein.
Peterson RT; Desai BN; Hardwick JS; Schreiber SL
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4438-42. PubMed ID: 10200280
[TBL] [Abstract][Full Text] [Related]
19. Regulation of eIF-4E BP1 phosphorylation by mTOR.
Hara K; Yonezawa K; Kozlowski MT; Sugimoto T; Andrabi K; Weng QP; Kasuga M; Nishimoto I; Avruch J
J Biol Chem; 1997 Oct; 272(42):26457-63. PubMed ID: 9334222
[TBL] [Abstract][Full Text] [Related]
20. Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway.
Wan X; Helman LJ
Neoplasia; 2002; 4(5):400-8. PubMed ID: 12192598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
